Unlike cancers infiltrating below the half of myometrial wall thickness, more advanced cancers presenting myometrial infiltration to a greater extent than the half of myometrium are characterized by a significant increase of TGFβR2 protein expression [211] (Table 1). The gene discussed is TGFBR2; the disease is cancer.